<?xml version="1.0" encoding="UTF-8"?>
<p>There were 48 new drugs licensed for the treatment of viral diseases in the UK during the 34-year period from 1981 to 2014, representing a mean 1.4 new drugs per year (
 <xref rid="BMJOPEN2015009333TB1" ref-type="table">table 1</xref>). Almost half of these drugs were licensed in the middle period (1993–2003, 48%), while just 15% were licensed in the earlier period (1981–1992). Over half of new drugs (54%) were initially indicated for HIV infection. The next most frequent initial indication was hepatitis C infection (15%), followed by infection with cytomegalovirus (13%), hepatitis B (8%), herpes simplex virus (4%), influenza virus (4%) and respiratory syncytial virus (2%, full details provided in online supplementary file 1).
</p>
